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Review article
Ανασκόπηση
   Glucose measurement using portable blood glucose meters in dogs and cats
Athanasiou L.V., Tsokana C.N., Saridomichelakis M.N.
Veterinary Faculty, University of Thessaly, 43100 Karditsa, Greece
  Η χρήση φορητής συσκευής για τη μέτρηση της συγκέντρωσης
της γλυκόζης στο αίμα στο σκύλο και τη γάτα
Αθανασίου Λ.Β., Τσοκανά Κ.Ν., Σαριδομιχελάκης Μ.Ν.
Τμήμα Κτηνιατρικής, Πανεπιστήμιο Θεσσαλίας, 43100 Καρδίτσα
ABSTRACT. Portable blood glucose meters (PBGMs) are small electronic devices that measure the concentration of 
glucose in whole blood. Due to the technological advances, measurement of glucose concentration is carried out in a 
small blood volume, and it is a relatively simple, quick and inexpensive procedure. PBGMs are frequently used in com-
panion animal medicine, especially for the diagnosis and treatment monitoring of dogs and cats with diabetes mellitus and 
hypoglycaemia. The main factors affecting the precision of the measurement include: a) the device (manufacturer), the 
consumables (reagent strips) and their storage conditions; b) environmental conditions (temperature and possibly altitude); 
c) blood collection technique (site of sampling, cleanliness at the site of sampling, use of anticoagulants); d) patient factors 
(haematocrit, blood triglycerides, creatinine, uric acid and protein concentrations, drug administration); and, e) operator 
errors. Due to all these factors, readings of glucose concentration by PBGMs may differ from those of chemistry analysers, 
and this should be taken into account when shifting from one method to the other. Furthermore, because the results depend 
on the PBGM, the same device should be used and all measurements should be made under the same environmental condi-
tions and using the same blood sampling technique for serial measurements of blood glucose to be comparable. Finally, 
all the above mentioned limitations of glucose measurement by PBGMs should be taken into consideration and the results 
should be interpreted along with the clinical signs and any other laboratory findings for optimal diagnostic and therapeutic 
decisions. 
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ΠΕΡΙΛΗΨΗ. Οι φορητές συσκευές για τη μέτρηση της συγκέντρωσης της γλυκόζης στο αίμα (γλυκοζόμετρα) είναι ηλε-
κτρονικές συσκευές που προσδιορίζουν τη συγκέντρωση της γλυκόζης στο ολικό αίμα. Χάρη στην εξέλιξη της τεχνολο-
γίας, ο προσδιορισμός αυτός πραγματοποιείται σε μικρό όγκο αίματος και αποτελεί απλή γρήγορη και χαμηλού κόστους 
διαδικασία. Τα γλυκοζόμετρα χρησιμοποιούνται συχνά στην ιατρική των ζώων συντροφιάς, ιδιαίτερα για τη διάγνωση 
και την παρακολούθηση της θεραπείας σκύλων και γατών με σακχαρώδη διαβήτη ή υπογλυκαιμία. Τα αποτελέσματα της 
μέτρησης της συγκέντρωσης της γλυκόζης με τα γλυκοζόμετρα επηρεάζονται από διάφορους παράγοντες, όπως: α) η ίδια 
η συσκευή, αφού το αποτέλεσμα ενδέχεται να διαφέρει μεταξύ γλυκοζόμετρων από διαφορετικούς κατασκευαστές, καθώς 
και τα αναλώσιμα (ταινίες) που τη συνοδεύουν και οι συνθήκες αποθήκευσης τους, β) οι περιβαλλοντικές συνθήκες, όπως 
είναι η θερμοκρασία και ενδεχομένως το υψόμετρο, γ) η τεχνική συλλογής του δείγματος (σημείο αιμοληψίας, καθαριότη-
τα του σημείου αιμοληψίας, συλλογή του δείγματος σε φιαλίδιο με αντιπηκτικό), δ) το ίδιο το ζώο, αφού το αποτέλεσμα 
επηρεάζεται από τον αιματοκρίτη, τη συγκέντρωση των τριγλυκεριδίων, της κρεατινίνης, του ουρικού οξέος και των πρω-
τεϊνών στο αίμα και τη χορήγηση ορισμένων φαρμάκων, και ε) τα σφάλματα ανάλυσης. Λόγω της επίδρασης των παραγό-
ντων αυτών, το αποτέλεσμα της μέτρησης ενδέχεται να διαφέρει σημαντικά όταν αυτή προσδιορίζεται με γλυκοζόμετρο 
σε σύγκριση με τους βιοχημικούς αναλυτές, γεγονός που πρέπει να λαμβάνεται υπόψη, ιδιαίτερα όταν δε χρησιμοποιείται 
η ίδια μέθοδος προσδιορισμού σε διαδοχικές μετρήσεις στο ίδιο ζώο. Επιπλέον, λόγω των διαφορών του αποτελέσμα-
τος μεταξύ συσκευών από διαφορετικούς κατασκευαστές, πρέπει να χρησιμοποιείται πάντα το ίδιο γλυκοζόμετρο και οι 
μετρήσεις να γίνονται κάτω από τις ίδιες περιβαλλοντικές συνθήκες και με την ίδια τεχνική αιμοληψίας προκειμένου να 
είναι συγκρίσιμα τα αποτελέσματα. Οι παραπάνω παράγοντες που επηρεάζουν τη συγκέντρωση της γλυκόζης στο αίμα 
όταν αυτή προσδιορίζεται με τη βοήθεια του γλυκοζόμετρου πρέπει να λαμβάνονται υπόψη και, όπως άλλωστε ισχύει για 
κάθε εργαστηριακή εξέταση, το αποτέλεσμα πρέπει να συνεκτιμάται με τα κλινικά και τα υπόλοιπα εργαστηριακά ευρή-
ματα για τη λήψη των καλύτερων διαγνωστικών και θεραπευτικών αποφάσεων.
Λέξεις ευρετηρίασης: γάτα, γλυκοζόμετρο, σκύλος, φορητή συσκευή μέτρηση της γλυκόζης
INTRODUCTION
Glucose, the principal source of energy for mam-malian cells, is derived from the diet, hepatic 
glyconeogenesis and hepatic and muscle glucogenoly-
sis, and its concentration in blood is under the control 
of various hormones, including insulin, glucagon, cor-
tisol, catecholamines and growth hormone (Feldman 
and Nelson, 2004; Knieriem et al., 2007). Glucose 
metabolism and blood concentrations are abnormal 
in many disease states (Table 1). For this reason, hy-
perglycaemia and hypoglycaemia are common labora-
tory findings in dogs and cats. Measurement of blood 
glucose concentration is essential whenever the clini-
cal picture is compatible with hyperglycaemia or hy-
poglycaemia (Table 2), whenever any of the possible 
underlying causes is included in the differentials list 
(Table 1), in all critical care patients, and for general 
health screening purposes (Villiers and Blackwood, 
2005; Wiedmeyer and DeClue, 2008; Ford and Lynch, 
2013; Surman and Fleeman, 2013). Furthermore, re-
peated measurements of blood glucose concentration 
are necessary to monitor and adjust the treatment of 
all the diseases that cause hyperglycaemia and hy-
poglycaemia and they are needed on a long-term to 
lifelong basis in dogs and cats with diabetes mellitus 
and insulinoma (Feldman and Nelson, 2004; Dietiker-
Moretti et al., 2011).
The methodology of glucose analysis is currently 
based on either chromogenic or electrochemical reac-
tions that are mediated by an enzyme, such as glu-
cose oxidase, glucose dehydrogenase and hexokinase 
(Kaneko et al., 2008; Johnson et al., 2009; Surman 
and Fleeman, 2013). These enzymatic methods have 
been applied in different equipment and devices, 
including in-house and reference laboratory auto-
mated chemistry analysers, point-of-care analysers, 
colorimetric reagent strips, portable blood glucose 
meters (PBMGs), and continuous glucose monitoring 
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 18/05/2020 02:01:04 |
J HELLENIC VET MED SOC 2014, 65(4)
ΠΕΚΕ 2014, 65(4)
ΑΘΑνΑσίΟυ Λ.Β., ΤσΟΚΑνΑ Κ.ν., σΑρίδΟμίΧΕΛΑΚησ μ.ν.                   275
Table 1. The most common causes of hyperglycaemia and hypoglycaemia in dogs and cats.
Table 2. Clinical signs of hyperglycaemia and hypoglycaemia in dogs and cats, irrespectively of the underlying cause.
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 18/05/2020 02:01:04 |
J HELLENIC VET MED SOC 2014, 65(4)
ΠΕΚΕ 2014, 65(4)
systems (CGMSs) (Wiedmeyer and DeClue, 2008; 
Surman and Fleeman, 2013).
Automated chemistry analysers are used by 
most commercial diagnostic laboratories as in-house 
equipment and they determine blood glucose con-
centrations in plasma or serum samples employing 
colorimetric endpoint or kinetic assays. The former 
are inaccurate with lipemic samples, since turbid-
ity decreases light transmittance, which is particu-
larly important for dogs and cats with diseases that 
simultaneously affect glucose and lipid metabolism, 
like diabetes mellitus. The latter detect changes in 
the optical density of the specimen over time. Other 
widely used methods for determination of blood 
glucose concentrations involve enzyme-catalysed 
reactions coupled to a colour detection system, oxi-
dation-reduction methods, and methods that result in 
the generation of an electrical current (Hagvik, 2007; 
Johnson et al., 2009). Although automated chemistry 
analysers are usually very accurate, their major dis-
advantages when used for the determination of blood 
glucose concentrations are the relatively large vol-
ume of blood and the long time to obtain the results. 
For these reasons, they are usually preferred when 
additional biochemical parameters, besides glucose, 
should be measured on a non-emergency setting 
(Surman and Fleeman, 2013).
Point-of-care analysers usually operate with dry 
chemistry slides or strips, require only small amounts 
of whole blood, serum or plasma, and provide rapid 
results. Besides glucose, they can also measure, 
using different slides or strips, other analytes that 
are helpful for the evaluation of the acid-base and 
the electrolyte status of the patient. For these reasons 
they are especially valuable in emergency cases. 
However, point-of-care analysers are relatively 
expensive and can only be used by trained personnel 
(Cohn et al., 2000).
Colorimetric reagent strips, which are read visu-
ally or with a reflectance meter, are available for esti-
mating glucose concentration in fresh whole blood 
(Sherwood et al., 1983). Currently, they are rarely, if 
ever, used because they are the least precise of all the 
available methods.
Portable blood glucose meters were originally 
developed to permit human diabetic patients to self-
monitor blood glucose concentration using a drop 
of capillary blood (Ginsberg, 2009a). Following 
an enzymatic reaction (glucose oxidase, glucose 
dehydrogenase, glucose oxidase-peroxidase) that is 
coupled to a chromogen or to an electron-donating 
mediator system, blood glucose concentration is 
measured via reflectance photometry (photometric 
methods) or via an electrode (electrochemical meth-
ods), respectively (Cohn et al., 2000; Johnson et al., 
2009; Surman and Fleeman, 2013; Ford and Lynch, 
2013). PBGMs are commonly used to measure blood 
glucose concentrations in dogs and cats. They require 
a small volume of venous or capillary blood, they 
have a relatively wide working range (from 10-20 to 
500-600 mg dL-1, depending on the device), they pro-
vide immediate results, they are of low cost and they 
are easy to handle, which permits their use even by 
animal owners after a short period of training (Cohen 
et al., 2009; Johnson et al., 2009; Dobromylskyj and 
Sparkes, 2010). These attributes make PBGMs the 
ideal way to measure blood glucose concentrations in 
emergency patients with hyperglycaemia or hypogly-
caemia, in all critical care patients and for the long-
term monitoring of diabetic dogs and cats in the 
hospital or at home (Alt et al., 2007; rios and Ward, 
2008; Cohen et al., 2009). The accuracy of PBGMs 
is highly important because the glucose readings that 
will be obtained will dictate the course of clinical 
action (Cohn et al., 2000).
Continuous glucose monitoring systems are also 
electronic devices that measure glucose concentra-
tions in the interstitial fluid with the aid of a small 
flexible sensor that is inserted into the subcutaneous 
tissue. The measurement is based on the glucose 
oxidase-mediated reaction between glucose and oxy-
gen (rios and Ward, 2008; Wiedmeyer and DeClue, 
2008; Moretti et al., 2010; Dietiker-Moretti et al., 
2011; Fleeman, 2011; Surman and Fleeman, 2013). 
Glucose concentrations in the blood and the inter-
stitial fluid are usually highly correlated, and the 
calibration of the CGMS using peripheral blood 
samples with known glucose concentrations per-
276 ATHANASIOU L.V., TSOKANA C.N., SArIDOMICHELAKIS M.N.
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In addition, PBGMs are indispensable for monitor-
ing of the emergency treatment of hyperglycaemia 
(e.g. regular insulin administration) or hypoglycae-
mia (e.g. dextrose infusion) which is based on seri-
al measurements of blood glucose concentrations 
(Feldman and Nelson, 2004; Koenig, 2013).
Non-diabetic critical care dogs and cats, with 
or without one of the known causes of hyperglycae-
mia (Table 1), may present disturbances of glucose 
metabolism leading to increased blood glucose con-
centrations (Knieriem et al., 2007). Possible underly-
ing mechanisms include increased adrenal secretion 
of glucocorticoids and catecholamines and insulin 
resistance, in addition to the possible hyperglycaemic 
effects of various therapeutic interventions (Knieriem 
et al., 2007). Increased blood glucose concentra-
tions have been correlated with the severity of head 
trauma in dogs and cats (Syring et al., 2001) and 
with a poor outcome in dogs with congestive heart 
failure (Brady et al., 2004) and perhaps in dogs with 
sepsis (Hardie et al., 1985). Intensive insulin therapy 
has been shown to reduce the incidence of complica-
tions and to improve prognosis in human critical care 
patients with hyperglycaemia (Van den Berghe et al., 
2003; Krinsley, 2004). Although there is a paucity 
of similar studies in companion animals, the use of 
regular insulin has been suggested in hyperglycaemic 
dogs and cats with head trauma or sepsis in an effort 
to strictly control blood glucose concentration in a 
range between 85 and 130 mg dL-1 (Knieriem et al., 
2007). Obviously, if this therapeutic intervention is 
adopted, repeated measurements of blood glucose 
concentrations with PBGMs is the only practical way 
to monitor treatment. At least in theory, a possible 
alternative could be the use of a CGMS with real-
time display of interstitial fluid glucose concentration 
(Wiedmeyer and DeClue, 2008).
Blood glucose curves (BGC) are essential for 
monitoring and adjusting insulin treatment of dogs 
and cats with diabetes mellitus (Alt et al., 2007; 
Martin and rand, 2007; rios and Ward, 2008; 
Affenzeller et al., 2011; Dietiker-Moretti et al., 2011; 
Smith et al., 2012; roomp and rand, 2013). They 
can be generated in either hospitalized patients or 
mits the device to accurately estimate blood glucose 
(rios and Ward, 2008; Wiedmeyer and DeClue, 
2008; Moretti et al., 2010; Dietiker-Moretti et al., 
2011; Hoenig et al., 2012; Surman and Fleeman, 
2013). CGMSs typically record glucose concentra-
tions every 3-5 minutes for up to 72 hours and are 
mainly used to regulate insulin treatment of stable 
diabetic dogs and cats (Wiedmeyer and DeClue, 
2008; Moretti et al., 2010; Dietiker-Moretti et al., 
2011; Fleeman, 2011; Surman and Fleeman, 2013). 
Additional indications may include monitoring of 
dogs and cats with diabetic ketoacidosis, of critical 
care patients, of dogs with juvenile hypoglycaemia 
as well as the intra- and post-operative monitoring of 
surgical patients at risk for hypoglycaemia or hyper-
glycaemia (Wiedmeyer and DeClue, 2008); however, 
the accuracy of CGMS for these purposes has not 
been fully evaluated and/or it is debatable (Surman 
and Fleeman, 2013).
INDICATIONS FOR USE OF PORTABLE 
BLOOD GLUCOSE METERS IN DOGS 
AND CATS
Hyperglycaemia or hypoglycaemia in dogs and 
cats (Table 1) may be an emergency, as in the case 
of ketoacidotic or hyperosmolar diabetes mellitus 
or hypoglycaemia-induced seizures (Dobromylskyj 
and Sparkes, 2010; Koenig, 2013). In such cases, 
the rapid diagnosis of abnormal blood glucose con-
centration is essential for the initial therapeutic deci-
sions. In all dogs and cats with clinical signs com-
patible with a diabetic emergency or with hypogly-
caemia (Table 2) measurement of blood glucose 
concentration with a PBGM is strongly advised as 
one of the initial diagnostic steps. If the blood glu-
cose readings of the PBGM are above or below the 
reference range, the result can be confirmed using 
an automated chemistry analyser, since a complete 
serum biochemical profile will be anyway necessary 
to identify the full range of biochemical abnormali-
ties that accompany diabetic emergencies or to inves-
tigate the cause of hypoglycaemia (Koenig, 2013). 
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range, thus necessitating periodic use of a PBGM 
and therapeutic decision-making may not significant-
ly differ depending on the use of CGMS or a PBGM 
(Moretti et al., 2010; Dietiker-Moretti et al., 2011; 
Fleeman, 2011).
Home monitoring of blood glucose concentra-
tion of diabetic dogs and cats decreases the medical 
cost (although it does not decrease the frequency of 
re-examinations), is feasible for most owners and 
it allows their active participation in the medical 
care of their pet (roomp and rand, 2009; Smith et 
al., 2012). Besides the traditional BGC that can be 
performed at home, current research suggests that 
especially in diabetic cats it is possible and safe to 
implement intense control of hyperglycaemia with 
a combination of long-acting insulin administration 
and dietary modifications, provided that the owners 
are willing and able to measure blood glucose con-
centration with a PBGM at least 3 times per day and 
optimally 5 times per day, on an everyday basis for a 
few weeks up to 4 months (roomp and rand, 2009; 
roomp and rand, 2013; Ford and Lynch, 2013). The 
intense protocol has the advantage that in more than 
80% of newly diagnosed cats diabetic remission can 
be achieved and insulin administration can be dis-
continued, on a temporary or even permanent basis 
(roomp and rand, 2009; roomp and rand, 2013).
Elective (e.g., neutering of female dogs) and 
non-elective surgery of diabetic dogs and cats poses 
a challenge in terms of controlling blood glucose 
concentration to avoid severe hyperglycaemia and 
hypoglycaemia. Lack of food intake, influence of the 
anaesthetic medication and the surgical stress on glu-
cose metabolism, and inability to monitor for clinical 
signs suggestive of abnormal blood glucose concen-
trations are the main considerations on the day of 
surgery and until the diabetic animal is awake and 
resumes eating. The typical recommendation during 
this period is to monitor blood glucose concentra-
tion every 30-60 min and to establish tight control 
(60-250 mg dL-1) with the administration of regu-
lar insulin and the appropriate fluid (normal saline 
0.9%, normal saline 0.45% and dextrose 2.5%, dex-
trose 5%) (Feldman and Nelson, 2004). Obviously, 
at home (Alt et al., 2007; rios and Ward, 2008; 
Dietiker-Moretti et al., 2011; Smith et al., 2012; 
roomp and rand, 2013; Ford and Lynch, 2013). 
Most diabetic pets are administered insulin twice 
daily; thus the BGC typically lasts for 10-12 hours 
and blood sampling for measurement of glucose 
concentration is typically performed every 1-2 hours 
during this period, although sampling every 3-4 
hours may be carried out in cats at home (Moretti et 
al., 2010; Affenzeller et al., 2011; Dietiker-Moretti et 
al., 2011; roomp and rand, 2013). Since an impor-
tant objective of the BGC is to determine the mini-
mum glucose concentration or nadir (Martin and 
rand, 2007; Dietiker-Moretti et al., 2011), more 
frequent sampling (usually every 30 min) is prac-
ticed by the authors during the period of maximum 
insulin activity (between 2 and 6 hours after insulin 
administration) and/or when a trend of progressively 
declining blood glucose concentration is noticed. 
Therefore, at least 7 and up to 20 or even more 
blood glucose measurements may be performed dur-
ing a BGC. Obviously, PBGMs and not automat-
ed chemistry analysers are used to measure blood 
glucose concentrations when BGC is conducted at 
home by the owner (Alt et al., 2007; Dobromylskyj 
and Sparkes, 2010; Ford and Lynch, 2013), and 
PBGMs are clearly preferred in the hospital environ-
ment due to the small blood volume that is required 
(avoidance of blood loss anaemia) and the option to 
use capillary instead of venous blood (less stress-
ful sampling). On the other hand, current data sug-
gest that CGMSs may be preferable over PBGMs 
for BGCs, mainly because of their superiority in 
terms of recording glucose nadir, zenith and daily 
fluctuations, of the option for continued monitoring 
of glucose concentrations for up 72 hours, and of 
the avoidance of repeated patient restrain for blood 
sampling (rios and Ward, 2008; Wiedmeyer and 
DeClue, 2008; Moretti et al., 2010; Affenzeller et al., 
2011; Dietiker-Moretti et al., 2011;). However, the 
cost to purchase the equipment may not be always 
affordable, the accuracy of the measurements may be 
lower compared to PBGMs, especially when blood 
glucose concentrations are at the hypoglycaemic 
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PBGMs are indispensable for the measurement of 
blood glucose concentrations and guiding treatment 
during this period.
The diagnosis of insulinoma is based on the nor-
mal or increased serum insulin concentration in the 
face of hypoglycaemia (<50-60mg dL-1) (Koenig, 
2013). In some dogs and cats with this tumour, blood 
glucose concentration fluctuates between low-nor-
mal and subnormal levels thus necessitating super-
vised fasting and repeated measurements in order to 
identify a hypoglycaemic serum sample where insu-
lin concentration can be measured (Ford and Lynch, 
2013; Koenig, 2013;). PBGMs are advised to monitor 
blood glucose concentration during the fasting period, 
although confirmation of hypoglycaemia in an auto-
mated chemistry analyser is needed before the serum 
sample is submitted to the laboratory for measurement 
of insulin concentration (Cohen et al., 2009)
FACTORS AFFECTING GLUCOSE 
MEASUREMENT BY PORTABE BLOOD 
GLUCOSE METERS
Different devices, employing different analytical 
methodologies, are characterized, not only by vari-
able method-specific interferences (e.g. the effect of 
blood oxygen tension on glucose oxidase method), 
but also by important differences in their inherent 
random (imprecision) and systematic (bias) error 
(Jensen and Kjelgaard-Hansen, 2006; Ginsberg, 
2009a; Johnson et al., 2009). In human medicine, the 
need for an internationally accepted reference meth-
od, like isotope dilution gas chromatography-mass 
spectrometry (Hagvik, 2007), to evaluate the accura-
cy and to calibrate blood glucose measuring devices, 
including PBGMs, has long been recognized. Until 
such a goal is achieved and is applicable for dogs and 
cats, it is recommended to consistently use the same 
device for the same patient, especially if monitoring 
of the trends in blood glucose concentration over time 
is clinically important (Johnson et al., 2009; Paul et 
al., 2011).
In general terms, the accuracy of blood glu-
cose concentrations that are measured by PBGMs 
differ depending on whether the equipment has 
been designed for human or for veterinary use, 
and for the former it also depends on whether they 
have been calibrated to measure whole blood or 
plasma-equivalent glucose concentrations (roomp 
and rand, 2013). More specifically, veterinary 
PBGMs, like AlphaTrak (Abbot Animal Health) 
and GlucoPet (Animal Diabetes) that have been 
specifically designed for dogs and cats (Cohen et 
al., 2009; Johnson et al., 2009; Moretti et al., 2010; 
Dietiker-Moretti et al., 2011; Ford and Lynch, 
2013), give plasma-equivalent glucose concentra-
tions that can be lower or higher but are strongly 
correlated with those expected with an automat-
ed chemistry analyser and the differences are not 
large enough to negatively affect clinical decisions 
or patient outcome (Cohen et al., 2009; Johnson 
et al., 2009; roomp and rand, 2009; Ford and 
Lynch, 2013; roomp and rand, 2013; Surman and 
Fleeman, 2013;). Other PBGMs for veterinary use 
include the g-Pet (Woodley Equipment) and the 
i-Pet (UltiCare); their accuracy seems to be ade-
quate based on manufacturers’ results but, at the 
time of writing, there are no independent studies 
published in the peer-reviewed literature to support 
this (Surman and Fleeman, 2013). On the contrary, 
most human whole-blood PBGMs, which are the 
most widely available devices, systemically under-
estimate glucose concentrations in dogs and cats (by 
as much as 16-40% or by approximately 18-36 mg 
dL-1 at normal and low glucose levels and at a great-
er extend for hyperglycaemic samples) and human 
plasma-equivalent PBGMs give intermediate values 
(Cohen et al., 2009; roomp and rand, 2009; Ford 
and Lynch, 2013; roomp and rand, 2013; Surman 
and Fleeman, 2013). The reason for this is suspected 
to be the different distribution of glucose between 
plasma (approximately 50% in humans, 87.5% in 
dogs and 93% in cats) and red blood cells (approxi-
mately 50% in humans, 12.5% in dogs and 7% in 
cats) along with the fact that the porous membrane 
of PBGMs test strips separates red blood cells from 
plasma and the analysis is performed only in the lat-
ter (Johnson et al., 2009; roomp and rand, 2009; 
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the PBGM should be confirmed by a chemistry ana-
lyser (Dobromylskyj and Sparkes, 2010).
Another important attribute of the device is the 
blood volume that is needed to obtain a reading, 
especially when lancing is employed to obtain a 
drop of capillary blood (Ford and Lynch, 2013; 
roomp and rand, 2013). Veterinary PBGMs, like 
AlphaTrak, that require small blood volume (e.g. 0.3 
μL) are preferable to those requiring larger volume 
(e.g. 0.6-4 μL for most human PBGMs or 1.5-1.6 
μL for the g-Pet and the i-Pet meters), because the 
chances to get an accurate reading are increased, 
especially if the device is used by the owners (Cohen 
et al., 2009; Ford and Lynch, 2013; roomp and 
rand, 2013; Surman and Fleeman, 2013).
Some human PBGMs can also measure blood 
b-hydroxybutyrate concentrations using different 
strips than those used to measure blood glucose con-
centrations (roomp and rand, 2013). In diabetic ani-
mals that develop ketosis blood b-hydroxybutyrate 
increases earlier than urine acetoacetic acid (which 
is predominantly measured with urine dipsticks) 
and for this reason such devices have the potential 
for earlier diagnosis of this complication of diabetes 
mellitus (roomp and rand, 2013).
Different reagent strips covered with a specific 
enzyme are used by all PBGMs. There is a strip-to-
strip variation, which may lead to some inaccuracy in 
blood glucose readings. Furthermore, slight variation 
in the size of the reaction wells of the strips as well 
as in their enzyme coverage (the amount of enzyme 
used and its dispersion on the well) may also influ-
ence the results (Ginsberg, 2009a). To account for 
the variation among different lots of strips, most 
PBGMs are calibrated for each new lot using a con-
trol solution, a lot-specific calibration strip or a lot-
specific code (Cohen et al., 2009; Johnson et al., 
2009).
The stability of the strips is guaranteed and the 
corresponding expiry date provided by the manu-
facturer is valid when they are stored in their tightly 
sealed package under the recommended storage con-
ditions. A shorter life span may result from high 
temperature, high humidity or a strip package that 
Surman and Fleeman, 2013). To further complicate 
this issue, the human PBGM Wavesense Presto 
(AgaMatrix) has been shown to give overall higher 
glucose concentration values, to overestimate low 
and to underestimate high glucose concentrations 
in cats (Hoenig et al., 2012) and in another study 
of six different human PBGMs in cats, both higher 
and lower glucose values than those obtained by a 
chemistry analyser were obtained (Dobromylskyj 
and Sparkes, 2010). For all these reasons, it is rec-
ommended to use a veterinary PBGM, and prefer-
ably one of those that have been evaluated in inde-
pendent studies, to measure blood glucose concen-
tration in dogs and cats. If this is not feasible due 
to lack of commercial availability, a human device 
(preferably a plasma-equivalent PBGM) that has 
been shown to be characterized by a systemic bias 
when used in dogs and cats should be selected and 
the results should be interpreted keeping in mind 
the expected error of the measurements (Table 3). 
For example, in diabetic cats treated with a long-
acting insulin and a very-low carbohydrate diet with 
the aim of achieving diabetic remission, the lower 
acceptable blood glucose concentration would be 
50 mg dL-1 or 80 mg dL-1 depending on whether a 
whole-blood human or a veterinary PBGM is used 
for home glucose monitoring, respectively (roomp 
and rand, 2009). Finally, any spurious results from 
Figure 1. After venous blood sampling, the needle has been 
removed from the syringe, and the reagent strip of the portable 
blood glucose meter is loaded using the drop of blood that has 
been created on the adaptor of the syringe.
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Table 3. Selected commercially available portable blood glucose meters (PBGMs) and their accuracy for measurement of blood 
glucose concentration in dogs and cats
a: C: cats; D: dogs; H: humans
b: NC: non-consistent overestimation and/or underestimation of blood glucose concentration; O: overestimation of blood glucose concentration;  
U: underestimation of blood glucose concentration
*1: bias increased at higher blood glucose concentrations 
Sources: (1) Cohen et al., 2009; (2) Johnson et al., 2009; (3) Cohn et al., 2000; (4) Wess and Reusch, 2000a; (5) Zini et al., 2009 (6) Wess and Re-
usch, 2000b (7) Wess and Reusch, 2000c (8) Dobromylskyj and Sparkes, 2010
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Figure 2. Capillary blood sampling from ear pinna of a dog for 
measurement of blood glucose concentration with a portable 
blood glucose meter: a) the margin of the pinna has been shaved; 
b) the puncture site is warmed with a damp cloth;  
c) a gauge is hold under the puncture site; d) the lancing device is 
opposed to the puncture site; e) a drop of capillary blood appears 
immediately after lancing; f) the capillary blood is used to load 
the reagent strip, and g) within a few seconds glucose reading 
appears on the screen of the portable blood glucose meter
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has been left open. In such cases, at least for humans, 
the divergence of the readings is unpredictable and 
underestimation or overestimation of blood glucose 
concentration may equally occur (Bamberg et al., 
2005). Therefore, strips should be stored properly and 
the package with the unused strips should be tightly 
closed immediately after the removal of a strip. Also, 
use of expired strips is strongly discouraged; some 
PBGMs automatically detect the expiration date and 
they alert the operator.
The accuracy of blood glucose measurements 
can be influenced by environmental factors, such as 
altitude and temperature. In addition to data provided 
by the manufacturers, the influence of these fac-
tors on the human applications of PBGMs has been 
assessed under extreme conditions (Gautier et al., 
1996). Glucose oxidase, but not glucose dehydroge-
nase, biosensor strips are sensitive to blood oxygen 
concentration. A decrease in blood oxygen concen-
tration that may occur at high altitude, can lead to 
overestimation of the glucose value and vice versa. 
For the same reason and because of the higher oxy-
gen concentration in capillary compared to venous 
blood, glucose oxidase strips may be more accurate 
when used with the former samples which have been 
used for their calibration. Furthermore, the accuracy 
of PBGMs using such strips may be compromised in 
patients receiving supplemental oxygen (Cohen et al., 
2009; Ginsberg, 2009b).
The influence of the temperature on glucose 
measurements is unpredictable. For this reason, tem-
perature sensors have been incorporated into modern 
PBGMs to warn operator against extreme tempera-
tures (Fazel et al., 1996; Oberg and Ostenson, 2005).
Blood glucose concentration measurement by 
PBGMs can be performed with venous or with capil-
lary blood samples and the latter can be obtained from 
different sites (ear pinnae or carpal/metacarpal pads). 
When capillary blood sampling is selected, the rea-
gent strip of the PBGM is directly touched to the drop 
of blood on the animal’s skin, whereas when venous 
blood is used a drop of blood from the syringe can be 
placed on the wrapper of the strip (Cohen et al., 2009) 
or a drop can be created on the adaptor of the syringe 
after removal of needle (Fig. 1). Different blood sam-
ples may affect readings due to differences in glucose 
and oxygen concentration, local blood circulation 
and possible contamination by natural or chemical 
substances. Apart from the higher oxygen tension, 
capillary blood also has higher glucose concentrations 
compared to venous blood, due to tissue utilization of 
glucose and this difference is higher postprandialy than 
during fasting (Johnson et al., 2009). However, capil-
lary and venous blood glucose concentrations seem to 
have a good correlation in companion animals (Alt et 
al., 2007; Cohen et al., 2009).
The most frequently used site for capillary blood 
sampling in dogs and cats is the lateral margin of the 
Figure 3. Capillary blood sampling from the carpal pad of a dog for measurement of blood glucose concentration with a portable blood 
glucose meter: a) the sampling site is pinched with two fingers; b) a drop of capillary blood appears immediately after lancing.
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use of anticoagulants (Wess and reusch, 2000b). 
However, in a different study evaluating feline blood 
samples without anticoagulant, with lithium heparin 
and with fluoride oxalate, no effect on glucose con-
centration was witnessed for six different human 
PBGMs (Dobromylskyj and Sparkes, 2010). This 
topic remains controversial but it is of minor clinical 
importance because PBGMs readings are typically 
obtained immediately after collection of capillary or 
venous blood samples without anticoagulant.
The haematocrit can influence blood glucose 
measurements by PMBGs. These devices meas-
ure glucose in a complex mixture of whole blood 
and plasma, while plasma glucose is used for their 
calibration during the manufacturing process. The 
effect of haematocrit is related, not only to the pres-
ence of glucose in red blood cells, but also to the 
influence of erythrocytes on various mechanisms 
operating during PBGM measurement, such as the 
diffusion of plasma to the test strip reagent pad, 
the enzymatic reaction and the proper function of 
the electrodes of the device (Wiener, 1991). For 
example, haemoconcentration and the associated 
increased blood viscosity may lead to obstruction of 
the holes of the strip filter and to a decreased plas-
ma diffusion rate and consequently, to falsely lower 
glucose readings, whereas artificially increased 
glucose concentrations are expected in anaemic 
patients (Tang et al., 2000). In general, PBGMs 
employing glucose dehydrogenase are suggested for 
human patients with abnormal haematocrit values 
and efforts have been made to apply mathematical 
equations for the correction of glucose readings for 
haematocrit values (Musholt et al., 2011).
The effect of the haematocrit is expected to also 
apply in dogs and cats (Paul et al., 2011) and perhaps 
to become more important with the use of human 
PBGMs which have been evaluated within the nar-
rower haematocrit range of humans. Although, a vet-
erinary PBGM was more accurate than a human one 
in canine blood samples with normal or increased 
haematocrit, the reverse was true in anaemic samples 
(Paul et al., 2011). In any case, PBGMs seem to con-
sistently overestimate blood glucose concentration in 
ear pinna (Ford and Lynch 2013) or the inner surface 
of the pinna (rios and Ward, 2008). Blood collec-
tion may be facilitated by shaving (lateral margin 
technique), warming the puncture site for 30-60 sec 
with a damp cloth, applying a thin layer of petro-
leum jelly, holding a cotton ball or a gauze under 
the pinna and pricking close to but not onto a vis-
ible vein (Ford and Lynch, 2013) (Fig. 2). recently, 
the carpal (pisiform or wrist) non-weight bearing 
pads of dogs and the metacarpal pad of cats have 
been also used and validated as alternative sampling 
sites for blood glucose testing (Zeugswetter et al., 
2010; Borin-Crivellenti et al., 2012; Ford and Lynch, 
2013). Sampling may become easier if the site is 
pre-warmed and lightly pinched with two fingers 
for a few seconds before and after puncture until an 
adequate blood drop forms (Ford and Lynch, 2013) 
(Fig. 3). Irrespectively of the site, puncture is typi-
cally performed with commercially available lancing 
devices with lancets of 25-32 gauge, depending on 
the patient (Ford and Lynch, 2013); some lancing 
devices create negative pressure which may facilitate 
ear pinna capillary blood sampling (rios and Ward, 
2008). One exception is for capillary blood sampling 
from the carpal pad in dogs, where a hypodermic 
needle may be more appropriate (Borin-Crivellenti et 
al., 2012).
The presence of contaminants at the site of sam-
pling, even in trace amounts, can significantly raise 
blood glucose, as it has been shown in human medi-
cine (Ginsberg, 2009a). Hand washing is suggested 
prior to blood sampling in humans and cleaning 
of the sampling site in dogs and cats can be pro-
posed. However, the use of any disinfectant should 
be avoided, until any possible effect of the substance 
on glucose measurement is excluded.
The effect of three anticoagulants (EDTA, lith-
ium heparin and fluoride) on glucose measurements 
in canine blood was determined for five different 
PBGMs. While no difference was found among 
EDTA, lithium heparin and blood without antico-
agulant, the concentration of glucose in fluoride-
anticoagulated blood was underestimated by one of 
the devices whose manufacturer advised against the 
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anaemic dogs (Johnson et al., 2009) and cats (Wess 
and reusch, 2000a), although a recent study did not 
reveal an effect of haematocrit on the accuracy of 
six different human PBGMs in feline blood samples 
(Dobromylskyj and Sparkes, 2010).
Plasma concentration of certain metabolites (i.e. 
triglycerides, creatinine, uric acid, proteins) have 
also been reported to influence the measurement 
of blood glucose in humans with PBGMs (Ervin 
and Kiser, 1999), more notably when their con-
centration is altered during certain diseases states. 
For example, high triglyceride concentration may 
decrease the amount of glucose in the capillary blood, 
whereas, uric acid at extreme concentrations errone-
ously increases glucose values (Ginsberg, 2009a). 
However, the latter effect is unlikely to be of clinical 
significance in companion animals due to the differ-
ences in purine metabolism compared to humans, and 
the effects of the other metabolites on the accuracy of 
PBGMs in dogs and cats have not been studied.
Various drugs, such as paracetamol, L-dopa, 
tolazamide, and ascorbic acid, interact with the elec-
trode of PBGMs employing the electrochemical glu-
cose oxidase system and alter glucose readings in 
human blood (Ginsberg, 2009a). To the author’s 
knowledge similar data are not available in the veteri-
nary literature.
The importance of following manufacturer’s 
instructions by the operator is fundamental for the 
accurate measurement of blood glucose concentra-
tion with PBGMs in both the hospital and the home 
setting. Operator error can become a major source of 
misleading results and therefore adequate training of 
operators is of great importance.
CONCLUDING REMARKS
Due to several factors, including the analytical 
method employed, results from different PBGMs 
are likely to differ. Even though such differenc-
es are not always clinically relevant and may not 
affect diagnostic or therapeutic decisions (Johnson 
et al., 2009), veterinary PBGMs should be preferred 
over human devices. If this is not feasible, human 
PBGMs that have been shown to be characterized 
by a systemic bias when used in dogs and cats must 
be selected. Furthermore, it is always a good idea to 
compare the results of any newly purchased PBGM 
with that of the previous device and/or of a chemical 
analyser.
Moreover, the clinician must be aware of the 
potential limitations of PBGMs and the factors that 
can interfere with the result, like storage condi-
tions, altitude, temperature, blood sampling method, 
haematocrit etc. For this reason, when consecutive 
measurements of blood glucose are necessary, as 
in diabetic animals, all these factors should remain 
as constant as possible so that any influence on the 
measured blood glucose concentration would be 
uniform.
Since the advent of the PBGMs, home monitor-
ing of diabetic dogs and cats has become feasible. 
Also, the immediate availability of the results offers 
an important advantage of PBGMs over automated 
chemistry analysers in the critical care setting. In 
any case, training of the operator, being either a 
pet owner or a health care provider, is essential to 
obtain reliable results. Finally, as with all diagnos-
tic tests and devices, the clinician should combine 
clinical judgment and experience with the measure-
ment of blood glucose concentration by PBGMs and 
interpret the result in light of all the information 
available.
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